SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bal Pharma informs about resignation of CS cum CO

12 May 2026 Evaluate
Bal Pharma has informed that Abdul Basith ( M.NO.A70640), Company Secretary & Compliance Officer of the Company has tendered his resignation vide his letter dated 2nd March, 2026 and the same has been accepted on 11.05.2026. Abdul Basith will be relieved from the services of the Company with effective from close of business hours on Monday, 11th May, 2026. The required details pursuant to the SEBI Listing Regulations are annexed as Annexure-I. Further communication is made about the appointment of new Company Secretary & Compliance Officer, all the communications in relation to the Company be sent to secretarial@balpharma.com 

The above information is a part of company’s filings submitted to BSE.

Bal Pharma Share Price

87.08 1.88 (2.21%)
09-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1779.40
Dr. Reddys Lab 1268.75
Cipla 1376.75
Zydus Lifesciences 1105.75
Lupin 2263.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×